LncRNA SNHG3 is activated by E2F1 and promotes proliferation and migration of non‐small‐cell lung cancer cells through activating TGF‐β pathway and IL‐6/JAK2/STAT3 pathway

Upregulation of SNHG3 expression associated with poor prognosis and enhances malignant progression of ovarian cancer

(2018) Lan Hong et al.   Cancer Biomarkers

Long non-coding RNA NNT-AS1 sponges miR-424/E2F1 to promote the tumorigenesis and cell cycle progression of gastric cancer

(2018) Beibei Chen et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Interleukin-6 and prostate cancer: Current developments and unsolved questions

(2018) Zoran Culig et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Long noncoding RNA UFC1 is activated by E2F1 and exerts oncogenic properties by functioning as a ceRNA of FOXP3

(2018) Jie Xi et al.   Cancer Medicine

LncRNA SNHG3 enhances the malignant progress of glioma through silencing KLF2 and p21

(2018) Fan Fei et al.   BIOSCIENCE REPORTS

Long noncoding RNA ROR promotes breast cancer by regulating the TGF-β pathway

(2018) LingLi Hou et al.   Cancer Cell International

LncRNA SNHG3 induces EMT and sorafenib resistance by modulating the miR-128/CD151 pathway in hepatocellular carcinoma

(2018) Peng-Fei Zhang et al.   JOURNAL OF CELLULAR PHYSIOLOGY

LINK-A promotes cell proliferation through the regulation of aerobic glycolysis in non-small-cell lung cancer

(2018) Wei Zhao et al.   OncoTargets and Therapy

SNHG8 is identified as a key regulator in non-small-cell lung cancer progression sponging to miR-542-3p by targeting CCND1/CDK6

(2018) Changhao Chen et al.   OncoTargets and Therapy

E2F1 induces LSINCT5 transcriptional activity and promotes gastric cancer progression by affecting the epithelial-mesenchymal transition

(2018) Peng Qi et al.   Cancer Management and Research

Regulation of CD44v6 expression in gastric carcinoma by the IL-6/STAT3 signaling pathway and its clinical significance

(2017) Yuan-Yuan Xu et al.   Oncotarget

Upregulated lncRNA SNHG1 contributes to progression of non-small cell lung cancer through inhibition of miR-101-3p and activation of Wnt/β-catenin signaling pathway

(2017) Yun Cui et al.   Oncotarget

Long non-coding RNA H19 regulates E2F1 expression by competitively sponging endogenous miR-29a-3p in clear cell renal cell carcinoma

(2017) Haowei He et al.   Cell and Bioscience

ANKRD22 promotes progression of non-small cell lung cancer through transcriptional up-regulation of E2F1

(2017) Jun Yin et al.   Scientific Reports

NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 4.2016

(2016) David S. Ettinger et al.   Journal of the National Comprehensive Cancer Network

Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials

(2015) Joe Y Chang et al.   LANCET ONCOLOGY

Update in lung cancer: Prologue to a modern review series

(2015) Nico van Zandwijk et al.   RESPIROLOGY

Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

(2014) M. Reck et al.   ANNALS OF ONCOLOGY

TGF-  Signaling in Myeloid Cells Is Required for Tumor Metastasis

(2013) Y. Pang et al.   Cancer Discovery

Cancer statistics, 2012

(2012) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Modular regulatory principles of large non-coding RNAs

(2012) Mitchell Guttman et al.   NATURE

The Long Noncoding MALAT-1 RNA Indicates a Poor Prognosis in Non-small Cell Lung Cancer and Induces Migration and Tumor Growth

(2011) Lars Henning Schmidt et al.   Journal of Thoracic Oncology

The Emergence of lncRNAs in Cancer Biology

(2011) J. R. Prensner et al.   Cancer Discovery

Evolution and Functions of Long Noncoding RNAs

(2009) Chris P. Ponting et al.   CELL